Bruker (BRKR) Cash & Equivalents (2010 - 2026)
Bruker's (BRKR) quarterly Cash & Equivalents came in at $133.4 million in Q1 2026, down 27.58% YoY from $184.2 million in Q1 2025, and down 55.35% on a QoQ basis from $298.8 million in Q4 2025.
Bruker (BRKR) Cash & Equivalents (2010 - 2026) Analysis & Trends
Bruker (BRKR) has 17 years of Cash & Equivalents data on file, last reported at $133.4 million in Q1 2026.
- Quarterly Cash & Equivalents fell 27.58% year-over-year to $133.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $133.4 million (down 27.58% YoY) and the FY2025 annual result came in at $298.8 million, up 62.92% from the prior year.
- Cash & Equivalents retreated to $133.4 million in Q1 2026, from $298.8 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $816.1 million in Q1 2022 to a low of $92.0 million in Q2 2025.
- A 5-year average of $392.8 million and a median of $340.1 million in 2024 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2024 — Cash & Equivalents sank 70.48% — and 2025, when it soared 97.91%.
- Tracing BRKR's Cash & Equivalents over 5 years: stood at $645.5 million in 2022, then retreated by 24.35% to $488.3 million in 2023, then sank by 62.44% to $183.4 million in 2024, then jumped by 62.92% to $298.8 million in 2025, then tumbled by 55.35% to $133.4 million in 2026.
- The last three Cash & Equivalents figures came in at $133.4 million (Q1 2026), $298.8 million (Q4 2025), and $293.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Bruker | 9.16 Bn | 9.16 Bn | 416.00 Mn | 184.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 184.90 Mn |
| Mar 31, 2026 | 133.40 Mn |
| Dec 31, 2025 | 298.80 Mn |
| Sep 30, 2025 | 293.10 Mn |
| Jun 30, 2025 | 92.00 Mn |
| Mar 31, 2025 | 184.20 Mn |
| Dec 31, 2024 | 183.40 Mn |
| Sep 30, 2024 | 148.10 Mn |
| Jun 30, 2024 | 169.70 Mn |
| Mar 31, 2024 | 340.10 Mn |
| Dec 31, 2023 | 488.30 Mn |
| Sep 30, 2023 | 363.60 Mn |
| Jun 30, 2023 | 574.80 Mn |
| Mar 31, 2023 | 597.90 Mn |
| Dec 31, 2022 | 645.50 Mn |
| Sep 30, 2022 | 626.20 Mn |
| Jun 30, 2022 | 723.00 Mn |
| Mar 31, 2022 | 816.10 Mn |
| Dec 31, 2021 | 1.07 Bn |
| Sep 30, 2021 | 573.00 Mn |